Canaccord Genuity analyst Richard Close reiterated a Buy rating and $4.50 price target on Clover Health (NASDAQ: CLOV).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE